Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy

Gynecologic Oncology

Volumn 94, Issue 3, 2004, Pages 636-642

  Wootipoom, Virach ^a   Lekhyananda, Nol ^a   Phungrassami, Temsak ^a   Boonyaphiphat, Pleumjit ^b   Thongsuksai, Paramee ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Bax; Bcl 2; Cervical carcinoma; p53; Prognosis

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 4444261662     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.03.012     Document Type: Article

References (32)

1. Deerasamee S., Srivatanakul P. Cervix uteri. Deerasamee S., Martin N., Sontipong S., Sriamporn H., Sriplung H., Srivatanakul P., Vatanasapt V., Parkin D.M., Ferley J. Cancer in Thailand 1992-1994. vol. II:1999;56-59 IARC, Lyon
2. Kerr J.F.R., Winterford C.M., Harmon B.V. Apoptosis: its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026
3. Kroemer G. The pro-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620
4. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6
5. Herod J.J.O., Eliopoulos A.G., Warwick J., Niedobitek G., Young L.S., Kerr D.J. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res. 56:1996;2178-2184
6. Bertheau P., Steinberg S.M., Merino M.J. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathological correlation. Hum. Pathol. 29:1998;323-329
7. Bulluco C., Guillem J.G., Kemeny N., Huang Y., Klimstra D., Berger M.F., et al. p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastasis. J. Clin. Oncol. 14:1996;2696-2701
8. Crawford R.A.F., Caldwell C., Iles R.K., Lowe D., Shepherd J.H., Chard T. Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer. Br. J. Cancer. 78:1998;210-214
9. Tjalma W.A., Weyler J.J., Bogers J.J., Pollefliet C., Baay M., Goovaerts G.C., et al. The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 97:2001;223-230
10. Harima Y., Harima K., Shikata N., Oka A., Ohnishi T., Tanaka Y. Bax and bcl-2 expressions predict response to radiotherapy in human cervical cancer. J. Cancer Res. Clin. Oncol. 124:1998;503-510
11. Chung T.K., Cheung T.H., Lo W.K., Yim S.F., Yu M.Y., Krajewski S., et al. Expression of apoptotic regulators and their significance in cervical cancer. Cancer Lett. 180:2002;63-68
12. Mukherjee G., Freeman A., Moore R., Kumaraswamy, Devi K.U., Morris L.S., et al. Biologic factors and response to radiotherapy in carcinoma of the cervix. Int. J. Gynecol. Cancer. 11:2001;187-193
13. Rajkumar T., Rajan S., Baruah R.K., Majhi U., Selvaluxmi G., Vasanthan A. Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix. Eur. J. Gynaecol. Oncol. 19:1998;556-560
14. Pillai M.R., Jayaprakash P.G., Nair M.K. bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma. J. Cancer Res. Clin. Oncol. 125:1999;55-60
15. Hall P.A., Meek D., Lane D.P. p53-integrating the complexity. J. Pathol. 180:1996;1-5
16. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805
17. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136
18. Skirnisdottir I., Seidal T., Gerdin E., Sorbe B. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy. Int. J. Gynecol. Cancer. 12:2002;265-276
19. Lipponen P., Ji H., Aaltomaa S., Syrjanen S., Syrjanen K. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int. J. Cancer. 55:1993;51-56
20. Couture C., Raybaud-Diogene H., Tetu B., Bairati I., Murry D., Allard J., et al. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer. 94:2002;713-722
21. Jain D., Srinivasan R., Patel F.D., Gupta S.K. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy. Gynecol. Oncol. 88:2003;22-28
22. Dimitrakakis C., Kymionis G., Diakomanolis E., Papaspyrou I., Rodolakis A., Arzimanoglou I., et al. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol. Oncol. 77:2000;129-136
23. Pecorelli S., Benedet J.L., Creasman W.T., Shepherd J.H. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int. J. Gynaecol. Obstet. 65:1999;243-249
24. Reed J.C., Miyashita T., Takayama S., Wang H.G., Sata T., Krajewski S., et al. Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem. 60:1996;23-32
25. Strasser A., Huang D.C.S., Vaux D.L. The role of bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim. Biophys. Acta. 1333:1997;F151-F178
26. Saegusa M., Takano Y., Hashimura M., Shoji V., Okayasu I. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer. 76:1995;2297-2303
27. Cheung T.H., Chung T.K., Lo K.W., Yu M., Krajewski S., Reed J.C., et al. Apoptosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix. Gynecol. Oncol. 86:2002;14-18
28. S expression in neoplastic and normal cervical tissue. Cancer Lett. 155:2000;19-27
29. Uehara T., Kuwashima Y., Izumo T., Kishi K., Shiromizu K., Matsuzawa M. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome. Eur. J. Gynecol. Oncol. 16:1995;453-460
30. Hendry J.H., West C.M.L. Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response. Int. J. Radiat. Biol. 71:1997;709-719
31. Ling C.C., Guo M., Chen C.H., Deloherey T. Radiation-induced apoptosis: effects of cell age and dose fractionation. Cancer Res. 55:1995;5207-5212
32. Meyn R.E., Stephens L.C., Hunter N.R., Ang K.K., Milas L. Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors. Int. J. Radiat. Oncol., Biol., Phys. 30:1994;619-624